World Vaccine Congress US 2025

July 21, 2025

Summary:

  • Protective immunity depends not just on antibody titers, but also on Fc effector functions that engage the immune system through phagocytosis, cytotoxicity, and complement activation.
  • Fc-mediated functions play a critical role in differentiating antibody quality, helping explain protection in the absence of high titers or neutralization.
  • Comprehensive profiling across diverse immune cell types provides a more accurate understanding of efficacy and safety for both vaccine candidates and therapeutic antibodies.
  • SeromYx’s high-throughput, antigen-specific assays and computational analytics offer powerful tools to identify correlates of protection and guide candidate selection.

Authors: 

Lenny Moise, PhD.

Download Presentation
July 23, 2025
Authors: Stefanutti E, Ramani R, Whitener B, Dang H, Bélanger S, Somasundaram L, Cortina K, De Marco A, Tam T, Chai Q, Cameroni E, Gupta R, Schmid MA, Miller JL, Zumsteg AB, Purcell LA, Drewry LL. 0. Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodies. Microbiol Spectr 0:e00863-25. Journal: Microbiology Spectrum 
June 4, 2025
Antibody Engineering & Therapeutics 2025
June 3, 2025
The World Vaccine Congress Europe 2025
June 2, 2025
Festival of Biologics
June 1, 2025
The Fc-Mediated Effector Function Summit
May 31, 2025
Authors: Kaplonek P, et al. Sci Transl Med. 2022 May 18;14(645):eabm2311.
May 31, 2025
Authors: Hawman, David W. et al. eBioMedicine, Volume 115, 105698
May 12, 2025
Authors: Crescioli, S, Jatiani, S, & Moise, L, (2025). mAbs, 17(1). Journal: mAbs
By Abigail Harris October 8, 2024
Woburn, MA / Newark, DE – October 1st, 2024 - SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, a leading provider for life science solutions and tools, are excited to announce the release of their joint study on the...
More Posts →